Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06723002 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

Study acronym: ACS_ATHEROLIV
StatusNot Yet Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 9, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
the study aims to examine the short-term (30 days) effects of olive leaf extract on endothelial function in patients with acute coronary syndrome (ACS). This investigation will be conducted on patients admitted to the emergency department for ACS. All participants will be screened and included within 24 hours post-ACS event and prior to discharge from the emergency department.
Trial Details
NCT Number NCT06723002
Lead Sponsor University of Monastir
Conditions
(from sponsor)		 Acute Coronary Syndrome (ACS), Reactive Hyperemia, Endothelial Dysfunction
Related terms Acute Coronary Syndrome, Hyperemia
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov